Support for Women with HER2+ Breast Cancer

Whether you'd like to get information, relax with a soothing meditation, or connect with others for support, 4HER is here for you.

Developed by Genentech (with some content in collaboration with Breastcancer.org), this easy-to-use app is exclusively for women with HER2+ Breast Cancer.

4HER Patient Support App

  • Find information about Breast Cancer
  • Explore questions to ask your doctor
  • Play a game whenever you need a break
  • Relax with guided meditation
  • Discover support resources and register for HERConnection, a free educational program that supports patients on select Genentech HER2+ Breast Cancer treatments
  • Connect with others, and more

Download the free app from Genentech on the App Store℠ or on Google Play™.

Download 4HER Patient Support App

Download 4HER Patient Support App

Learn

4HER Patient Support App

We've collaborated with Breastcancer.org to bring you information about HER2+ Breast Cancer, as well as health and lifestyle tips. Also, you'll find additional resources that may be helpful.

Play

Play a fun game whenever you need a break.

4HER Patient Support App

A fun way to pass the time during infusions or whenever you need a little diversion.

Relax

Take a little break from the day with soothing, guided meditations.

4HER Patient Support App

Three meditations to choose from: 5, 10, and 20 minutes in length.

Connect*

Connect with other patients and resources, to get information and support.

4HER Patient Support App

  • Connect with other Breast Cancer patients
  • Call the Patient Support Line
  • Speak to a Genentech financial support specialist
  • Learn about cancer support groups

*To protect your privacy, you control what information you want to share. Genentech does not have visibility into the interactions of those participating in Patient Connect. Participants in this feature are connecting directly with each other outside Genentech systems.


Download the free app from Genentech on the App Store℠ or on Google Play™

The information you find in the Genentech 4HER app is not meant to replace the advice of your healthcare team. Please talk with your healthcare team about your medical condition and treatment. Only your doctor and healthcare team can give you medical advice.

Some content in collaboration with

Apple, the Apple logo and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App store is a service mark of Apple Inc.

Google Play is a trademark of Google Inc.

What does PERJETA treat?

PERJETA® (pertuzumab) is approved for use in combination with Herceptin® (trastuzumab) and docetaxel in people who have HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-HER2 therapy or chemotherapy for metastatic breast cancer.

PERJETA® (pertuzumab) is approved for use prior to surgery in combination with Herceptin® (trastuzumab) and docetaxel in people with HER2-positive, locally advanced, inflammatory, or early stage (tumor is greater than 2 cm in diameter or node positive) breast cancer. PERJETA should be used as part of a complete treatment regimen for early stage breast cancer. This use of PERJETA is based on an improvement in the percentage of patients whose cancer shrinks or disappears after treatment. Currently, no data have shown whether or not treatment with PERJETA prior to surgery improves survival.

  • The safety of PERJETA in combination with doxorubicin-containing regimens has not been established
  • The safety of PERJETA administered for greater than 6 cycles for early-stage breast cancer has not been established.

Important Safety Information

What should I know about side effects with PERJETA?

  • Not all people have serious side effects; however, side effects with PERJETA therapy are common. It is important to know what side effects may happen and what symptoms you should watch for
  • Your doctor may stop treatment if serious side effects happen. Be sure to contact your healthcare team right away if you have questions or are worried about any side effects

What are the most serious side effects?

  • PERJETA may cause heart problems, including those without symptoms (such as reduced heart function) and those with symptoms (such as congestive heart failure).
  • Your doctor may run tests to monitor your heart function before and during treatment with PERJETA
  • Based on test results your doctor may hold or discontinue treatment with PERJETA

Receiving PERJETA during pregnancy can result in the death of an unborn baby and birth defects.

  • Birth control should be used while receiving PERJETA and for 7 months after your last dose of PERJETA. If you are a mother who is breastfeeding, you should talk with your doctor about either stopping breastfeeding or stopping PERJETA
  • If you think you may be pregnant, you should contact your healthcare provider immediately
  • If you are exposed to PERJETA during pregnancy, or become pregnant while receiving PERJETA or within 7 months following the last dose of PERJETA in combination with Herceptin, you are encouraged to enroll in the MotHER Pregnancy Registry by contacting 1-800-690-6720 or visiting http://www.motherpregnancyregistry.com/ and report PERJETA exposure to Genentech at 1-888-835-2555

What are other possible serious side effects?

  • PERJETA should not be used in patients who are allergic to pertuzumab or to any of the ingredients in PERJETA
  • Infusion-related reactions: PERJETA is a medicine that is delivered into a vein through a needle. This process can cause reactions known as infusion-related reactions. The most common infusion-related reactions when receiving PERJETA, Herceptin, and docetaxel were feeling tired, abnormal or altered taste, allergic reactions, muscle pain, and vomiting. The most common infusion-related reactions when receiving PERJETA alone were fever, chills, feeling tired, headache, weakness, allergic reactions, and vomiting
  • Severe allergic reactions: Some people receiving PERJETA may have severe allergic reactions, called hypersensitivity reactions or anaphylaxis. This reaction may be severe, may happen quickly, and may affect many areas of the body

How will my doctor and I know if PERJETA is right for me?

PERJETA has only been shown to work in people with HER2-positive breast cancer. You must have a HER2 test to know if your breast cancer is HER2-positive before receiving an anti-HER2 treatment, such as PERJETA.

What are the most common side effects?

The most common side effects of PERJETA when given with Herceptin and docetaxel for treatment of breast cancer that has spread to other parts of the body (metastatic) are:

  • Diarrhea
  • Hair loss
  • Low levels of white blood cells with or without a fever
  • Nausea
  • Feeling tired
  • Rash
  • Damage to the nerves (numbness, tingling, pain in hands/feet)

The most common side effects of PERJETA when given with Herceptin and docetaxel as part of an early breast cancer regimen before surgery are:

  • Hair loss
  • Diarrhea
  • Nausea
  • Low levels of white blood cells with or without a fever

The most common side effects of PERJETA when given with Herceptin and docetaxel following 3 cycles of epirubicin, cyclophosphamide, and fluorouracil as part of an early breast cancer regimen before surgery are:

  • Feeling tired
  • Hair loss
  • Diarrhea
  • Nausea
  • Vomiting
  • Low levels of white blood cells with or without a fever

The most common side effects of PERJETA when given with Herceptin, docetaxel, and carboplatin as part of an early breast cancer regimen before surgery are:

  • Feeling tired
  • Hair loss
  • Diarrhea
  • Nausea
  • Vomiting
  • Low levels of white blood cells with or without a fever
  • Low platelet count
  • Low levels of red blood cells

You are encouraged to report side effects to Genentech and the FDA. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.

Please see additional select Important Safety Information throughout, and the accompanying full Prescribing Information including most serious side effects.